Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.3%
    Check dated 2024-06-13T22:22:54.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the data related to a research study on a new weekly medicine for controlling blood sugar levels in people with Type 2 Diabetes.
    Difference
    0.3%
    Check dated 2024-06-06T14:36:25.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of relevant medical or healthcare-related publications or documentation. This change may reflect the addition of a new study or document in the database.
    Difference
    0.3%
    Check dated 2024-05-22T21:30:55.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:32:42.000Z thumbnail image

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.